Related references
Note: Only part of the references are listed.Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
Regulation of HIV-1 Latency by Chromatin Structure and Nuclear Architecture
Marina Lusic et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Genome editing strategies: potential tools for eradicating HIV-1/AIDS
Kamel Khalili et al.
JOURNAL OF NEUROVIROLOGY (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Weijun Zhu et al.
RETROVIROLOGY (2015)
Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
Hsin-Kai Liao et al.
NATURE COMMUNICATIONS (2015)
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review
Olurotimi A. Adejumo et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Wenhui Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina et al.
SCIENTIFIC REPORTS (2013)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Jean Bennett et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
RNAi medicine for the brain: progresses and challenges
Ryan L. Boudreau et al.
HUMAN MOLECULAR GENETICS (2011)
CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection:: a novel model of HIV-1 latency
Suha Saleh et al.
BLOOD (2007)
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli
WJ Swiggard et al.
JOURNAL OF VIROLOGY (2005)
Gene therapy of Canavan disease:: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain
C Janson et al.
HUMAN GENE THERAPY (2002)
HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy
L Barisoni et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
